Literature DB >> 23745038

Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.

Christopher Ma1, Brennan Walters, Richard N Fedorak.   

Abstract

Opportunistic viral infections are a well-recognized complication of anti-tumor necrosis factor (TNF) therapy for inflammatory bowel disease (IBD). Cases of severe or atypical varicella zoster virus infection, both primary and latent reactivation, have been described in association with immunosuppression of Crohn's disease (CD) patients. However, central nervous system varicella zoster virus infections have been rarely described, and there are no previous reports of varicella zoster virus meningitis associated with anti-TNF therapy among the CD population. Here, we present the case of a 40-year-old male with severe ileocecal-CD who developed a reactivation of dermatomal herpes zoster after treatment with prednisone and adalimumab. The reactivation presented as debilitating varicella zoster virus meningitis, which was not completely resolved despite aggressive antiviral therapy with prolonged intravenous acyclovir and subsequent oral valacyclovir. This is the first reported case of opportunistic central nervous system varicella zoster infection complicating anti-TNF therapy in the CD population. This paper also reviews the literature on varicella zoster virus infections of immunosuppressed IBD patients and the importance of vaccination prior to initiation of anti-TNF therapy.

Entities:  

Keywords:  Adalimumab; Anti-tumor necrosis factor; Crohn’s disease; Infliximab; Meningitis; Varicella zoster virus; corticosteroids

Mesh:

Substances:

Year:  2013        PMID: 23745038      PMCID: PMC3671088          DOI: 10.3748/wjg.v19.i21.3347

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

Review 1.  Neurologic complications of the reactivation of varicella-zoster virus.

Authors:  D H Gilden; B K Kleinschmidt-DeMasters; J J LaGuardia; R Mahalingam; R J Cohrs
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

2.  ZOSTER MENINGOENCEPHALITIS IN A STEROID-TREATED PATIENT.

Authors:  J TAKO; J P RADO
Journal:  Arch Neurol       Date:  1965-06

3.  Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.

Authors:  Michael S Simberkoff; Robert D Arbeit; Gary R Johnson; Michael N Oxman; Kathy D Boardman; Heather M Williams; Myron J Levin; Kenneth E Schmader; Lawrence D Gelb; Susan Keay; Kathleen Neuzil; Richard N Greenberg; Marie R Griffin; Larry E Davis; Vicki A Morrison; Paula W Annunziato
Journal:  Ann Intern Med       Date:  2010-05-04       Impact factor: 25.391

Review 4.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  Disseminated varicella complicating ulcerative colitis.

Authors:  J K Keene; D K Lowe; J L Grosfeld; J F Fitzgerald; F Gonzales-Crussi
Journal:  JAMA       Date:  1978-01-02       Impact factor: 56.272

6.  Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease.

Authors:  Daniel Wendling; Gérald Streit; Eric Toussirot; Clément Prati
Journal:  Joint Bone Spine       Date:  2008-07-31       Impact factor: 4.929

Review 7.  The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease.

Authors:  Matthew J Shale
Journal:  Br Med Bull       Date:  2009       Impact factor: 4.291

Review 8.  The neurotropic herpes viruses: herpes simplex and varicella-zoster.

Authors:  Israel Steiner; Peter G E Kennedy; Andrew R Pachner
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

9.  Adalimumab safety in global clinical trials of patients with Crohn's disease.

Authors:  Jean-Frédéric Colombel; William J Sandborn; Remo Panaccione; Anne M Robinson; Winnie Lau; Ju Li; Alexandra T Cardoso
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

10.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22
View more
  4 in total

Review 1.  Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors:  Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

Review 2.  Central Nervous System Infections Associated with Immunosuppressive Therapy for Rheumatic Disease.

Authors:  Michael J Bradshaw; Tracey A Cho; Felicia C Chow
Journal:  Rheum Dis Clin North Am       Date:  2017-08-23       Impact factor: 2.670

Review 3.  Structural brain lesions in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Hatice Dolapcioglu
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

4.  Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease.

Authors:  Shinichiro Tsurukawa; Nozomi Iwanaga; Yasumori Izumi; Atsunori Shirakawa; Chieko Kawahara; Tetsuo Shukuwa; Miwako Inamoto; Atsushi Kawakami; Kiyoshi Migita
Journal:  Case Rep Rheumatol       Date:  2016-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.